Naim Shares Recent Research Advances at the Controlled Release Society Annual Meeting
Naim Hage was recently selected for a podium presentation position at the 41st Annual Meeting & Exposition of the Controlled Release Society in Chicago, USA.
The talk, entitled ‘A biomimetic strategy for gastric targeting based on Helicobacter pylori’, focused on the biophysical properties of a recombinant protein, engineered in the Falcone lab in collaboration with AstraZeneca R&D. This recombinant protein is based on a bacterial adhesion molecule and shows promising use as a targeting moiety for attaching nanoscale drug carriers to the gastric epithelium.
The Controlled Release Society publishes the Journal of Controlled Release, Drug Delivery and Translational Research, and Biomaterials.
Naim addresses an audience in a scientific session concerning
overcoming the biological barriers of the GI tract
July 2014, Chicago